Clinical and epidemiological characteristics of 646 hospitalised SARS-Cov-2 positive patients in Rivers State Nigeria: a prospective observational study
INTRODUCTION: the knowledge of epidemiologic and clinical variables in patients with SARS- CoV-2 infection provides evidence and lessons that are useful for the pandemic response, with consideration of National and sub-National variations. The objective of this study was to characterize and describe the clinical and epidemiologic features of all the hospitalised patients with COVID-19 in Rivers State Nigeria, from March to August 2020. METHODS: a prospective descriptive multi-center study of patients with positive SARS-CoV-2 RT PCR, who were hospitalised for treatment and self-isolation in four treatment centers in Rivers state, Nigeria. RESULTS: the mean age of all the patients was 39.21 ± 12.31 years, with a range of 2 to 77 years. The majority of patients were in the 31 to 40-year (33.0%), 41 to 50-year (23.1%) and 18-to 30-year (22.0%) age groups. The patient population included 474 (73.4%) males and 172 (26.6%) females, with 93 (14.4%) healthcare workers. A history of contact and travel was established in 38.5% and at least one comorbid disease condition was present in 32.8% of patients. Patients with severe disease were 61 (9.45%), while the overall case fatality rate was 2%. The leading comorbid disease conditions were Hypertension in 23.8% and diabetes in 7.7% of patients. Fever (26.0%), dry Cough (17.6%), dyspnoea (12.7%), anosmia (12.7%) and headache (9.9%) were the most common symptoms. The presence of comorbidity and increasing age predicted death from COVID-19. CONCLUSION: the clinical and epidemiologic characteristics of this cohort of hospitalised patients show significant similarities with existing trends from previously reported studies, with contextual peculiarities..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
The Pan African Medical Journal - 38(2021), 25 Zur Gesamtaufnahme - volume:38 |
|---|
| Sprache: |
Englisch ; Französisch |
|---|
| Beteiligte Personen: |
Datonye Alasia [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Characteristics |
|---|
| doi: |
10.11604/pamj.2021.38.25.26755 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ018391648 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ018391648 | ||
| 003 | DE-627 | ||
| 005 | 20230310100109.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.11604/pamj.2021.38.25.26755 |2 doi | |
| 035 | |a (DE-627)DOAJ018391648 | ||
| 035 | |a (DE-599)DOAJf79e5a4716e34b1aad059168e56396d8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a fre | ||
| 100 | 0 | |a Datonye Alasia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical and epidemiological characteristics of 646 hospitalised SARS-Cov-2 positive patients in Rivers State Nigeria: a prospective observational study |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a INTRODUCTION: the knowledge of epidemiologic and clinical variables in patients with SARS- CoV-2 infection provides evidence and lessons that are useful for the pandemic response, with consideration of National and sub-National variations. The objective of this study was to characterize and describe the clinical and epidemiologic features of all the hospitalised patients with COVID-19 in Rivers State Nigeria, from March to August 2020. METHODS: a prospective descriptive multi-center study of patients with positive SARS-CoV-2 RT PCR, who were hospitalised for treatment and self-isolation in four treatment centers in Rivers state, Nigeria. RESULTS: the mean age of all the patients was 39.21 ± 12.31 years, with a range of 2 to 77 years. The majority of patients were in the 31 to 40-year (33.0%), 41 to 50-year (23.1%) and 18-to 30-year (22.0%) age groups. The patient population included 474 (73.4%) males and 172 (26.6%) females, with 93 (14.4%) healthcare workers. A history of contact and travel was established in 38.5% and at least one comorbid disease condition was present in 32.8% of patients. Patients with severe disease were 61 (9.45%), while the overall case fatality rate was 2%. The leading comorbid disease conditions were Hypertension in 23.8% and diabetes in 7.7% of patients. Fever (26.0%), dry Cough (17.6%), dyspnoea (12.7%), anosmia (12.7%) and headache (9.9%) were the most common symptoms. The presence of comorbidity and increasing age predicted death from COVID-19. CONCLUSION: the clinical and epidemiologic characteristics of this cohort of hospitalised patients show significant similarities with existing trends from previously reported studies, with contextual peculiarities. | ||
| 650 | 4 | |a epidemiology | |
| 650 | 4 | |a characteristics | |
| 650 | 4 | |a sars-cov-2 | |
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a nigeria | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Golden Owhonda |e verfasserin |4 aut | |
| 700 | 0 | |a Omosivie Maduka |e verfasserin |4 aut | |
| 700 | 0 | |a Ifeoma Nwadiuto |e verfasserin |4 aut | |
| 700 | 0 | |a Godswill Arugu |e verfasserin |4 aut | |
| 700 | 0 | |a Charles Tobin-West |e verfasserin |4 aut | |
| 700 | 0 | |a Esther Azi |e verfasserin |4 aut | |
| 700 | 0 | |a Victor Oris-Onyiri |e verfasserin |4 aut | |
| 700 | 0 | |a Inwon Joseph Urang |e verfasserin |4 aut | |
| 700 | 0 | |a Victor Abikor |e verfasserin |4 aut | |
| 700 | 0 | |a Ayo-Maria Olofinuka |e verfasserin |4 aut | |
| 700 | 0 | |a Obelebra Adebiyi |e verfasserin |4 aut | |
| 700 | 0 | |a Abiye Somiari |e verfasserin |4 aut | |
| 700 | 0 | |a Hope Avundaa |e verfasserin |4 aut | |
| 700 | 0 | |a Alali Aloni |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t The Pan African Medical Journal |g 38(2021), 25 |
| 773 | 1 | 8 | |g volume:38 |g year:2021 |g number:25 |
| 856 | 4 | 0 | |u https://doi.org/10.11604/pamj.2021.38.25.26755 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/f79e5a4716e34b1aad059168e56396d8 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.panafrican-med-journal.com/content/article/38/25/pdf/25.pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1937-8688 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1937-8688 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2021 |e 25 | ||